Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study

Brittany Knick Ragon, Nitin Jain, Maria R. Baer et al.|Clinical Lymphoma Myeloma & Leukemia|2019

Cited by 67